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Abstract: B a c k g r o u n d: A novel paradigm of diastolic heart failure with preserved ejection frac-
tion (HFpEF) proposed the induction of coronary microvascular dysfunction by HFpEF comorbidities 
via a systemic pro-infl ammatory state and associated oxidative stress. Th e consequent nitric oxide de-
fi ciency would increase diastolic tension and favor fi brosis of adjacent myocardium, which implies not 
only left  ventricular (LV), but all-chamber myocardial stiff ening. Our aim was to assess relations between 
low-grade chronic systemic infl ammation and left  atrial (LA) pressure-volume relations in real-world 
HFpEF patients. 
M e t h o d s: We retrospectively analyzed medical records of 60 clinically stable HpEFF patients in sinus 
rhythm with assayed high-sensitive C-reactive protein (CRP) during the index hospitalization. Subjects 
with CRP >10 mg/L or coexistent diseases, including coronary artery disease, were excluded. LV and LA 
diameters and mitral E/E’ ratio (an index of LA pressure) were extracted from routine echocardiographic 
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records. A surrogate measure of LA stiff ness was computed as the averaged mitral E/e’ ratio divided by 
LA diameter. 
R e s u l t s: With ascending CRP tertiles, we observed trends for elevated mitral E/e’ ratio (p <0.001), 
increased relative LV wall thickness (p = 0.01) and higher NYHA functional class (p = 0.02). Th e LA stiff -
ness estimate and log-transformed CRP levels (log-CRP) were interrelated (r = 0.38, p = 0.003). On multi-
variate analysis, the LA stiff ness index was independently associated with log-CRP (β ± SEM: 0.21 ± 0.07, 
p = 0.007) and age (β ± SEM: 0.16 ± 0.07, p = 0.03), which was maintained upon adjustment for LV mass 
index and relative LV wall thickness. 
C o n c l u s i o n s: Low-grade chronic infl ammation may contribute to LA stiff ening additively to age and 
regardless of the magnitude of associated LV hypertrophy and concentricity. LA stiff ening can exacerbate 
symptoms of congestion in HFpEF jointly with LV remodeling.
Key words: heart failure with preserved ejection fraction, low-grade chronic infl ammation, left  atrium, 
left  ventricle, echocardiography.
Introduction
Heart failure with preserved ejection fraction (HFpEF) accounts for almost half of heart 
failure (HF) patients and is the most prevalent form of HF in the elderly. HFpEF has 
been traditionally attributed to excessive left  ventricular (LV) aft erload [1]. A  recent 
novel HFpEF paradigm highlights the induction of a  systemic pro-infl ammatory 
state in HFpEF by coexistent comorbidities such as hypertension, obesity, diabetes 
or chronic kidney disease [1]. Th e  pro-infl ammatory state and associated oxidative 
stress in turn cause coronary microvascular endothelial dysfunction, i.e. defi cient 
bioavailability of endothelium-derived nitric oxide. Depressed nitric oxide 
bioavailability lowers protein kinase G activity in adjacent cardiomyocytes, which 
subsequently slows down LV relaxation, increases resting tension of cardiomyocytes, 
stimulates collagen deposition and favors cardiomyocyte hypertrophy [1, 2]. 
Th is novel conceptualization of HFpEF implies a contribution of low-grade chronic 
systemic infl ammation not only to LV stiff ening but also to depressed left  atrial (LA) 
and right atrial compliance [1]. Recent analyses of atrial pressure-volume relations 
support the notion that myocardial stiffening in HFpEF is not chamber-specific, 
including both atria [3–5]. Assuming this inflammatory model of HFpEF, the 
degree of chronic low-level systemic infl ammatory activation is expected to impact 
both LA and LV stiff ness in HFpEF. Associations among hypertensive subjects have 
been reported between C-reactive protein (CRP) levels and both LV hypertrophy 
and its concentricity [6–8] as well as reduced compliance of the large arteries [9]. 
Similar relationships were also observed in cohorts recruited from the general 
population [10, 11]. However, LA pressure-volume relations according to the degree 
of systemic infl ammatory activation in HFpEF have so far not been described to the 
best of our knowledge. 
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Th erefore, our aim was to assess associations between CRP levels and a surrogate 
measure of LA stiffness derived from medical records of real-world patients 
with HFpEF.
Methods
Patients
We retrospectively analyzed medical records of patients hospitalized at a  cardiology 
department for a  planned coronary angiography across a  period of about 4 years. 
Coronary angiography was performed in order to exclude coronary artery disease, 
owing to inconclusive exercise ECG or stress imaging.
First, we selected the records of patients with clinically suspected HF and 
preserved sinus rhythm, in whom serum CRP was assessed with a  high-sensitivity 
assay during the index hospitalization as a part of routine blood analysis at admission. 
Then subjects with a  final diagnosis of HFpEF were identified, on the basis of 
symptoms or signs typical of HF (New York Heart Association [NYHA] functional 
class II−III), LV ejection fraction (EF) ≥50% without LV dilation, echocardiographic 
evidence of LV hypertrophy/LA enlargement and/or LV diastolic dysfunction, and the 
absence of probable non-cardiac causes of symptoms suggestive of HF, in agreement 
with the 2016 European Society of Cardiology guidelines for the management 
of  HF  [12]. LV diastolic dysfunction was diagnosed in accordance with the 2016 
joint recommendations of the American Society of Echocardiography and European 
Association of Cardiovascular Imaging [13]. 
Exclusion criteria — in addition to unstable clinical conditions (acute coronary 
syndrome, marked congestion, hypotension, poorly controlled hypertension) — 
included coronary diameter narrowings ≥50%, congenital heart disease, more than 
mild valvular heart disease, CRP >10 mg/L, pulmonary diseases, estimated glomerular 
fi ltration rate <30 mL/min per 1.73 m2 (using the Modifi cation of Diet in Renal 
Disease [MDRD] Study formula), infl ammatory, proliferative and other coexistent 
diseases (except for well-controlled diabetes), as well as signifi cant abnormalities in 
routine blood and urine assays.
Procedure
Th e  following parameters were extracted from cardiac ultrasound performed during 
the index hospitalization by a  well-trained experienced sonographer according to 
a  standard protocol: 2D-guided M-mode measurements of LV dimensions and 
LV wall thickness, end-systolic anteroposterior LA diameter, EF (by the modifi ed 
Simpson’s rule), peak early diastolic trans-mitral fl ow velocity (E) and mean mitral 
annular velocity (e’) averaged from recordings taken at the lateral and septal region of 
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the mitral annulus [13, 14]. LV mass index was computed by the Devereux formula, 
and relative LV wall thickness was estimated as an index of LV concentricity [14]. 
Then, a  surrogate measure of LA stiffness was calculated according to an 
approach described below. LA stiff ness was previously approximated as the slope of 
the regression line that connects minimal and maximal pressure-volume coordinates 
on the LA pressure-volume diagram following a  figure-of-eight pattern [5, 15]. 
Admittedly, we were not able to derive this slope from routine echocardiographic 
records. However, Melenovsky et al. [5] have shown that changes in the slope, 
refl ecting altered LA stiff ness, were accompanied by corresponding changes in the 
same direction in the LA pressure/volume ratio at the time of mitral valve opening, i.e. 
at maximal LA volume. Averaged mitral E/e’ ratio is an index of LA pressure at mitral 
valve opening [16], while LA diameter, conventionally measured at end-systole [14], 
roughly refl ects maximal LA volume. Accordingly, the mean mitral E/e’ ratio divided 
by LA diameter can be treated as a surrogate estimate of LA pressure-volume relations 
at mitral valve opening, and, consequently, LA stiff ness.
The  ethics committee of our university approved the protocol (Approval 
No. 122.6120.228.2016) and the fact that patients’ consent was not sought owing to 
a retrospective study design.
Statistical analysis 
Data were presented as means (SD) or n (%). Patients’ characteristics were compared 
between CRP tertiles by analysis of variance or chi-squared test for continuous and 
categorical data, respectively. Trend eff ects across CRP tertiles were assessed by 
Spearman’s rank order correlation coeffi  cient (rho) for both types of data. Pearson’s 
correlation coeffi  cients (r) were computed in search for univariate correlates of CRP 
levels and the LA stiff ness estimate. CRP concentrations were log-transformed due to 
a non-normal distribution. A p-value below 0.05 was inferred as signifi cant.
In order to identify independent determinants of the LA stiff ness index, multiple 
linear regression was performed with forward stepwise selection of covariates; p-to 
enter and p-to-remove values were set at 0.10 and 0.15, respectively. 
All analyses were performed by means of STATISTICA (data analysis soft ware 
system), version 12 (StatSoft , Inc., Tulsa, OK, USA).
Results
Out of 323 potentially eligible patients, 60 clinically stable subjects with an 
established diagnosis of HFpEF entered the fi nal analysis based on the exclusion 
criteria. Characteristics of the study patients according to CRP tertile are presented 
in Table 1.
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Table 1. Clinical and echocardiographic patients’ characteristics according to CRP tertile.
Characteristics
CRP tertile
p* pfor trend†I (<1.3)
[mg/L]
II (1.3–2.4)
[mg/L]
III (>2.4)
[mg/L]
Clinical characteristics
Age, years 68 ± 9 71 ± 7 70 ± 7 NS NS
Female gender, n (%) 10 (50%) 10 (50%) 12 (60%) NS NS
NYHA class, II/III, n 17/3 11/9 10/10 0.04  0.02
Diabetes, n (%)  7 (35%)  6 (30%)  7 (35%) NS NS
Hypertension, n (%) 17 (85%) 16 (80%) 18 (90%) NS NS
Hypertension duration, years 9 ± 7 12 ± 5 11 ± 5 NS NS
Body-mass index, kg/m2 28.8 ± 4.40 28.7 ± 4.7 29.5 ± 3.8 NS NS
Mean blood pressure, mmHg‡ 99 ± 9 97 ± 8 98 ± 10 NS NS
eGFR, mL/min per 1.73 m2 70 ± 10 69 ± 11 72 ± 12 NS NS
Echocardiographic characteristics
LVd at end-diastole, mm 49 ± 6 48 ± 6 48 ± 4 NS NS
Ejection fraction, % 71 ± 6 71 ± 8 70 ± 8 NS NS
LV mass index, g/m2 106 ± 24 122 ± 37 123 ± 26 0.15  0.07
Relative LV wall thickness 0.46 ± 0.09 0.51 ± 0.08 0.52 ± 0.06 0.06  0.01
LAd at end-systole 44 ± 3 46 ± 3 46 ± 4 0.15  0.12
Mitral E/e’ ratio 10.6 ± 2.6 12.8 ± 2.1 13.5 ± 3.0 0.002 <0.001
LA stiff ness index, a.u. 2.4 ± 0.6 2.8 ± 0.4 3.0 ± 0.7 0.01  0.004
Data are presented as mean ± standard deviation or n (%). 
* By analysis of variance or chi-squared test for continuous and categorical data, respectively.
† By Spearman’s rank order correlation coeffi  cient (rho).
‡ Averaged from in-hospital blood pressure measurements.
a.u. — arbitrary units; CRP — C-reactive protein; eGFR — estimated glomerular fi ltration rate by the MDRD 
Study formula; LA — left  atrial; LAd — anteroseptal LA diameter in the parasternal long-axis view; LV — left  
ventricular; LVd — LV internal dimension in the parasternal long-axis view; Mitral E/e’ ratio — peak early 
diastolic transmitral fl ow velocity divided by mean mitral annular velocity averaged from measurements taken at 
the lateral and septal region of the mitral annulus; NS — non-signifi cant; NYHA — New York Heart Association. 
With ascending CRP tertiles, we observed significant trends for elevated 
mitral E/e’ ratio (p <0.001), increased relative LV wall thickness (p = 0.01), and higher 
NYHA functional class (p = 0.02). Corresponding tendencies were weak for LV mass 
index (p = 0.07) and LA diameter (p = 0.12). Consequently, categorized CRP levels 
strongly correlated with the LA stiff ness index (Table 1). 
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The  LA stiffness estimate and log-transformed CRP levels (log-CRP) were 
interrelated (r = 0.38, p = 0.003) (Fig. 1). In addition, log-CRP correlated with relative 
LV wall thickness (r = 0.35, p = 0.007), LA diameter (r = 0.27, p = 0.04) and weakly 
with LV mass index (r = 0.24, p = 0.07). Th e  LA stiff ness index was related to age 
(r = 0.32, p = 0.01) and weakly to time elapsed since hypertension diagnosis (r = 0.22, 
p = 0.12). 
a.u. — arbitrary units; r — Pearson’s correlation coeffi  cient.
Fig. 1. Left  atrial stiff ness surrogate index vs. log-transformed C-reactive protein levels. 
Table 2. Forward stepwise multiple regression of the left  atrial stiff ness surrogate measure (adjusted R2 
for the regression equation: 0.18, p = 0.001).
Predictor variable SD β Mean ± SEM p
Age, years 7.60 0.16 ± 0.07 0.03
log (CRP [mg/L]) 0.37 0.21 ± 0.07 0.007
β — semi-standardized regression coeffi  cient, equivalent to a  rise in the LA stiff ness index associated with 1-SD 
increase in each predictor; SD — standard deviation; SEM — standard error of the mean; other abbreviations as 
in Table 1.
On multivariable analysis, the LA stiff ness index was independently associated 
with log-CRP and age (Table 2). Th e  results virtually did not change aft er LV mass 
index, relative LV wall thickness, EF and body-mass index were also forced into the 
fi nal regression model.
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Discussion
We found a  signifi cant association between CRP and a  surrogate measure of LA 
stiff ness in a retrospective analysis of clinically stable real-world HFpEF patients. Th is 
association was particularly noteworthy for being additive to the eff ect of age and 
independent of CRP relations with the magnitude of LV hypertrophy or concentricity. 
Although a  correlation does not imply a  cause-and-eff ect relationship, our fi ndings 
are consistent with the notion that chronic low-grade chronic systemic infl ammation 
may contribute to all-chamber myocardial stiff ening in HFpEF [1–5]. 
Mechanistic considerations 
As early as 30 years ago, utilizing computer-based simulations Th omas  et  al.  [17,  18] 
revealed that not only lower LV compliance but also depressed LA compliance might 
result in LA pressure elevation as a  compensatory mechanism to keep LV fi lling 
volume (equal to LV stroke volume) relatively constant. Th is mechanism promotes 
pulmonary congestion and the development of pulmonary hypertension. Th ese 
model-based theoretical predictions were elegantly verifi ed in an in vitro analog of the 
left  heart [17] and patients undergoing percutaneous balloon mitral valvuloplasty [19]. 
In the latter study [19], net atrioventricular compliance, determined by both LA and 
LV compliance, impacted trans-mitral pressure half-time independently of mitral valve 
area and the maximal early trans-mitral pressure gradient. 
Net atrioventricular compliance has recently re-gained attention in mitral stenosis 
as a predictor of symptoms development irrespective of stenosis severity [20] and both 
persistent pulmonary hypertension and adverse outcome despite successful mitral 
valvuloplasty  [21]. Additionally, LA stiff ening accounts for the stiff  LA syndrome, 
presenting as HF and pulmonary hypertension due to LA diastolic dysfunction [22]. 
Th e  stiff  LA syndrome had initially been described in a  patient 7 years aft er mitral 
valve surgery despite normal prosthesis function  [23], and later was identifi ed as 
a  rare complication of radiofrequency ablation for atrial fi brillation [22]. Finally, 
increased pre-procedural LA stiff ness has recently been implicated in the recurrence 
of atrial fi brillation aft er ablation [24].
In regards to HFpEF, LA stiff ening was found responsible for lower LA volume 
despite identical mean LA pressure compared to HF with reduced EF [5]. LA size 
is accordingly not only a  barometer of an average effect of LV filling pressures 
over time and a  predictor of incident HF and adverse outcome in various clinical 
settings  [25,  26], but is also modulated by LA compliance. Notably, depressed LA 
compliance resulted in higher pulsatility of LA pressure with consequently increased 
variation of LA wall stress during the cardiac cycle [5]. Th is fi nding was suggested to 
underlie a higher risk of atrial fi brillation in this form of HF [5, 27]. 
52 Cyrus M. Sani, Elahn P.L. Pogue, et al.
LA stiff ening may also play a role in the transition from asymptomatic LV diastolic 
dysfunction to overt HFpEF. Kurt et al. [28] observed that elevated LA stiff ness index, 
calculated as the ratio of pulmonary capillary wedge pressure (or mitral E/e’) to 
LA strain during ventricular systole, accurately distinguished HFpEF patients from 
subjects with asymptomatic LV diastolic dysfunction. Recently, in an animal model 
of early hypertensive HFpEF, Zakeri et al. [29] demonstrated a  2.5-fold increase in 
the modulus of LA chamber stiff ness, which, jointly with LA myocyte hypertrophy, 
altered titin phosphorylation and endothelium-dependent LA microvascular 
dysfunction, is consistent with the notion that adverse LA remodeling contributes to 
HFpEF development.
Additionally, both systolic and diastolic LA function, quantifi ed by speckle-tracking 
echocardiography, were more impaired in patients with HFpEF compared to those 
with asymptomatic diastolic dysfunction, and determined functional capacity [30]. 
Finally, low peak late mitral annular velocity, refl ecting LA contractile function, was 
the only independent predictor of a composite of all-cause death or HF hospitalization 
in HFpEF [31]. Th erefore, both systolic and diastolic LA dysfunction, corresponding 
to disturbed LA active contractile and passive reservoir function, respectively, are of 
clinical importance in HFpEF, thus explaining independent adverse prognostic eff ects 
of reduced active [5, 32] or total LA emptying fraction [5, 26, 32]. 
Study limitations
Owing to the study design, we estimated the magnitude of chronic low-level 
infl ammatory activation through a  single measurement of CRP, while a  more reliable 
index index — e.g. averaging long term follow-up readings of an infl ammatory marker 
— would be preferred. However, all patients were in stable clinical condition which, in 
addition to the application of a wide set of exclusion criteria, limited the heterogeneity 
of the study group, keeping in mind a  high prevalence of multimorbidity in elderly 
HF subjects [33]. Moreover, prior to the index hospitalization and in-hospital CRP 
assay, virtually all patients (57 out of 60 analyzed subjects) — referred for a  planned 
coronary angiography — were receiving standard medication according to practice 
guidelines, including statins and angiotensin-converting enzyme inhibitors, known to 
reduce serum infl ammatory markers [34, 35]. 
Second, on the basis of available past medical records, we were able to calculate 
only a  surrogate simplifi ed measure of LA stiff ness, which is an imprecise estimate 
of the LA pressure-volume relationship    [5, 15]. In particular, strain imaging would 
have given a better insight into LA [28, 30] mechanics, nevertheless, this technique 
was not performed in the study subjects. Additionally, LA volume determinations are 
preferred over linear dimensions [13, 14], however, only anteroseptal LA diameter in 
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the parasternal long-axis view was available in the majority of the analyzed medical 
records. 
Third, it would be appropriate to include additional covariates in multiple 
regression; nonetheless, the retrospective design and study size limited the number of 
potential confounders. 
Conclusions
Low-grade chronic systemic infl ammation may contribute to LA stiff ening additively 
to age and regardless of the magnitude of associated LV hypertrophy and concentricity. 
LA stiff ening can exacerbate symptoms of congestion in HFpEF jointly with LV 
remodeling. Th e  utility of potential modulatory interventions remains to be studied 
in both counteracting global cardiac stiff ening and slowing down HFpEF progression.
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